IONS - Ionis Pharmaceu Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 WKHS (2.91%) U (1.12%) THO (-0.47%) SPY (-1.35%) RACE (-0.42%) PYPL (1.9%) NVDA (-0.1%) HEPA (-4.94%) FURY (0.82%) CWH (2.01%) CRIS (-1.18%) AU (-2.88%) AMC (-2.43%) ABNB (1.21%)

IONS - Ionis Pharmaceutical...

$37.79 0.31[0.83%]

15 mins delayed data

People also watch : AZN | SGMO | DGX | BMY | PFE | ALNY

+Watchlist

1 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$37.48	Open	$37.20
Volume	2.25M	Market Cap	5.283B
Yield		Last Dividend

Day

52 Week

Ionis'' Chief Scientific Officer C. Fran...	06/14/21
CARLSBAD, Calif., June 14, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that Executive Vice President and Chief Sci...

Ionis Pharmaceuticals (IONS) Investor Pr...	06/11/21
No summary available.

Ionis'' antisense therapies in ATTR amyl...	06/10/21
CARLSBAD, Calif., June 10, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapies, today announced that...

Ionis announces changes to its board of ...	06/02/21
CARLSBAD, Calif., June 2, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced changes to its board of directors. Joseph Lo...

Ionis: Price Slump Is An Opportunity To ...	06/02/21
No summary available.

Ionis to present at upcoming investor co...	05/25/21
Ionis Pharmaceuticals, Inc. announced that management will present a company overview at the following virtual investor conferences

Artiva Biotherapeutics Appoints Two New ...	05/18/21
Artiva Biotherapeutics appoints Elizabeth L. Hougen, EVP and CFO of Ionis Pharmaceuticals, Inc., has extensive experience in finance and business for ...

Good News For Ionis Pharmaceuticals, Inc...	05/12/21
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) price is hovering higher on Wednesday, May 12, jumping 1.59% above its previous close. Get the hottest stock...

Ionis Pharmaceuticals (NASDAQ:IONS) Pric...	05/12/21
Ionis Pharmaceuticals (NASDAQ:IONS) had its target price dropped by equities researchers at Morgan Stanley from $38.00 to $35.00 in a note issued to i...

NN Investment Partners Holdings N.V. Sel...	05/12/21
NN Investment Partners Holdings N.V. trimmed its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) by 16.7% in the first quarter, according...

Ionis Pharmaceuticals Inc. Shares Close ...	03/26/21
Ionis Pharmaceuticals Inc. shares closed this week 20.8% lower than it did at the end of last week. The stock is currently down 24.0% year-to-date, d...

Ionis Pharmaceuticals Inc. Shares Near 5...	03/23/21
Ionis Pharmaceuticals Inc. shares closed today at 0.9% above its 52 week low of $42.91, giving the company a market cap of $6B. The stock is currentl...

Ionis Pharmaceuticals Inc. Shares Near 5...	01/25/21
Ionis Pharmaceuticals Inc. shares closed today at 2.0% below its 52 week high of $63.78, giving the company a market cap of $8B. The stock is current...

Ionis Pharmaceuticals Inc. Shares Approa...	01/21/21
Ionis Pharmaceuticals Inc. shares closed today at 1.9% below its 52 week high of $62.95, giving the company a market cap of $8B. The stock is current...

Ionis Pharmaceuticals Inc. Shares Close ...	12/18/20
Ionis Pharmaceuticals Inc. shares closed the week 18.6% higher than it did at the end of last week. The stock is currently down 10.1% year-to-date, d...

ANALYST RATINGS

6 analyst ratings (Last 3 months)

50.00 %

Strong Buy + Buy

Price Target (PT)

Sell rating	04/19/21
Morgan Stanley maintains Underweight rating and lowers Price Target from $43.00 to $38.00

Buy rating	03/23/21
SVB Leerink maintains Market Perform rating and lowers Price Target from $50.00 to $36.00

Sell rating	03/23/21
Morgan Stanley maintains Underweight rating and lowers Price Target from $50.00 to $43.00

Buy rating	03/23/21
Needham maintains Buy rating and lowers Price Target from $95.00 to $86.00

Strong Buy rating	03/23/21
BMO Capital maintains Outperform rating and lowers Price Target from $90.00 to $76.00

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $IONS

No traders tracking are currently recommending this stock

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.